Baader Bank Aktiengesellschaft’s China SXT Pharmaceuticals SXTC Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13	Closed	-$7.93K	–	492
2024 Q3	$7.93K	Buy	+13	New	+$14.1K	﹤0.01%	414
2023 Q4	–	Hold	0	–	-$1.42K	–	388
2023 Q3	–	Hold	0	–	–	–	313

Other funds holding SXTC

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baader Bank Aktiengesellschaft's SXTC Position: Q4 2024 in Review

Baader Bank Aktiengesellschaft sold out of China SXT Pharmaceuticals (SXTC) in Q4 2024, closing a stake of 13 shares — an estimated $7.93K sold.

Baader Bank Aktiengesellschaft first reported a position in SXTC in Q3 2024 and held it in 1 quarter. The position peaked at $7.93K in Q3 2024. 1 fund tracked by Wall St. Rank holds SXTC as of Q4 2024.

Baader Bank Aktiengesellschaft reported no remaining China SXT Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 13 China SXT Pharmaceuticals shares in Q4 2024, an estimated $7.93K.
Baader Bank Aktiengesellschaft first reported a position in China SXT Pharmaceuticals in Q3 2024 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's China SXT Pharmaceuticals position peaked at $7.93K in Q3 2024.
1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q4 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2024, filed 23 Jan 2025.